menu
    • menu

    Company profile for Akamis Bio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PsiOxus Therapeutics has changed its name to Akamis Bio.Akamis Bio is a clinical-stage oncology company whose mission is to leverage its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to positively impact the lives of people living with cancer. To achieve that mission, the company is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system t...
    PsiOxus Therapeutics has changed its name to Akamis Bio.Akamis Bio is a clinical-stage oncology company whose mission is to leverage its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to positively impact the lives of people living with cancer. To achieve that mission, the company is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system to recognize, attack, and clear their cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Akamis Biounitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    4-10, The Quadrant, Abingdon Science Park, Barton Lane, Abingdon, Oxfordshire,...
    Telephone
    Telephone
    +44 (0)1235 835328
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.akamisbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/akamisbio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Akamis Bio Granted FDA Fast Track For NG-350A In Rectal Cancer
    Akamis Bio Granted FDA Fast Track For NG-350A In Rectal Cancer

    14 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251014497355/en/Akamis-Bio-Receives-FDA-Fast-Track-Designation-for-NG-350A-for-the-Treatment-of-Mismatch-Repair-Proficient-Locally-Advanced-Rectal-Cancer

    BUSINESSWIRE
    14 Oct 2025
    Share Share
    Akamis Bio Appoints Andrew Hirsch to Board of Directors
    Akamis Bio Appoints Andrew Hirsch to Board of Directors

    12 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250812956455/en/Akamis-Bio-Announces-the-Appointment-of-Andrew-Hirsch-to-the-Companys-Board-of-Directors

    BUSINESSWIRE
    12 Aug 2025
    Share Share
    Akamis Bio Expands Leadership Team with Key Appointments
    Akamis Bio Expands Leadership Team with Key Appointments

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250506214222/en/Akamis-Bio-Broadens-Leadership-Team-with-Key-Executive-Appointments

    BUSINESSWIRE
    06 May 2025
    Share Share
    Akamis Bio Enrolls 1st Patient in Phase 1b FORTRESS Trial of NG-350A
    Akamis Bio Enrolls 1st Patient in Phase 1b FORTRESS Trial of NG-350A

    03 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250403722186/en/Akamis-Bio-Announces-Enrollment-of-First-Patient-in-Phase-1b-FORTRESS-Trial-of-NG-350A-in-Patients-with-Locally-Advanced-Rectal-Cancer

    BUSINESSWIRE
    03 Apr 2025
    Share Share
    Akamis Bio Highlights Data Showing Potential of its Adenovirus Vector Technology
    Akamis Bio Highlights Data Showing Potential of its Adenovirus Vector Technology

    03 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231003536032/en

    BUSINESSWIRE
    03 Oct 2023
    Share Share
    Akamis Bio Strengthens Leadership Team with Key Executive Appointments
    Akamis Bio Strengthens Leadership Team with Key Executive Appointments

    06 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230706228074/en

    BUSINESSWIRE
    06 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search